Amidate and Duoneb drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amidate (etomidate) and Duoneb (albuterol sulfate; ipratropium bromide). Common drug interactions include sepsis among females and cytokine release syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Amidate and Duoneb. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Amidate?

Amidate has active ingredients of etomidate. eHealthMe is studying from 161 Amidate users. Check the latest studies of Amidate.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.



On Jul, 12, 2026

15 people who take Amidate and Duoneb together, and have interactions are studied.

Amidate and Duoneb drug interactions.

What are the common drug interactions of Amidate and Duoneb, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Hepatic failure (liver failure)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Abdominal distension
  5. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Cardiac failure congestive
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Ileus (a painful obstruction of the ileum or other part of the intestine)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Decreased appetite
  3. Cytokine storm (over-protective immune response that can actually be fatal)
  4. Death
  5. Dyspepsia (indigestion)
  6. Fungaemia (fungi circulate in the blood)
  7. Glomerular filtration rate decreased
  8. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  9. Muscle spasms (muscle contraction)
  10. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Amidate and Duoneb, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hepatic failure (liver failure)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  3. Confusional state
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Ileus (a painful obstruction of the ileum or other part of the intestine)
  6. Infection
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Renal failure (kidney dysfunction)
  10. Acute respiratory distress syndrome

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 20.00%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 20.00%
  4. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 13.33%
  5. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 13.33%
  6. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 13.33%
  7. Stable Angina (a constant chest pain): 2 people, 13.33%
  8. Nausea And Vomiting: 2 people, 13.33%
  9. Nausea (feeling of having an urge to vomit): 2 people, 13.33%
  10. Cardiac Failure Congestive: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amidate and Duoneb?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amidate and Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amidate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duoneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on etomidate and albuterol sulfate; ipratropium bromide (the active ingredients of Amidate and Duoneb, respectively), and Amidate and Duoneb (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: